Beyond Air (XAIR) Stock Price, News & Analysis

Company Overview

Beyond Air, Inc. is a medical device and biopharmaceutical company focused on developing nitric oxide (NO) therapies for respiratory conditions. The company’s technology is designed to generate nitric oxide from ambient air and deliver it directly to patients, potentially reducing the need for traditional high-pressure nitric oxide cylinders.

Its primary platform, LungFit, includes systems intended to produce and administer nitric oxide at the point of care. LungFit PH is designed for use in hospitals to deliver nitric oxide to term and near-term newborns with hypoxic respiratory failure associated with pulmonary hypertension. Beyond Air has also been developing additional LungFit applications for other pulmonary conditions, including respiratory infections and pulmonary hypertension.

Beyond Air serves the hospital and acute-care markets, primarily in the United States, while pursuing broader commercial and regulatory opportunities. The company is headquartered in Garden City, New York. Steven Lisi has served as Beyond Air’s chairman and chief executive officer.

Key Stats

• Today's Range: $3.00 to $3.20
• 50-Day Range: $3.01 to $6.92
• 52-Week Range: $3.00 to $55.60
• Volume: 36,649 shs
• Average Volume: 557,334 shs
• Market Capitalization: $2.88 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $105.00
• Consensus Rating: Moderate Buy

Beyond Air Stock Analysis - MarketRank™

Beyond Air scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Beyond Air has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Beyond Air has a consensus price target of $105.00, representing about 3,388.4% upside from its current price of $3.01.

Amount of Analyst Coverage

Beyond Air has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Beyond Air is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Beyond Air is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Beyond Air has a P/B Ratio of 0.32. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.46% of the float of Beyond Air has been sold short.

Short Interest Ratio / Days to Cover

Beyond Air has a short interest ratio ("days to cover") of 0.08, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Beyond Air has recently increased by 164.54%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Beyond Air does not currently pay a dividend.

Dividend Growth

Beyond Air does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

Only 2 people have searched for XAIR on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

MarketBeat Follows

3 people have added Beyond Air to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 4.3 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of Beyond Air in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $224,997.00 in company stock, which represents 7.8027% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Beyond Air insiders have bought more of their company's stock than they have sold. Specifically, they have bought $224,997.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

9.99% of the stock of Beyond Air is held by insiders.

Percentage Held by Institutions

31.50% of the stock of Beyond Air is held by institutions.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 9/23/2026
• Next Earnings (Estimated): 11/10/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:XAIR
• CIK: 1641631
• Web: www.beyondair.net
• Phone: (516) 665-8200
• Fax: N/A
• Employees: 54
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Beyond Air: $105.00
• High Price Target: $200.00
• Low Price Target: $10.00
• Potential Upside/Downside: +3,388.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($68.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$33.25 million
• Net Margins: -435.71%
• Pretax Margin: -447.64%
• Return on Equity: -440.26%
• Return on Assets: -98.50%

Debt

• Debt-to-Equity Ratio: 7.81
• Current Ratio: 3.31
• Quick Ratio: 3.12

Sales & Book Value

• Annual Sales: $7.69 million
• Price / Sales: 0.38
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.41 per share
• Price / Book: 0.32

Miscellaneous

• Outstanding Shares: 958,000
• Free Float: 862,000
• Market Cap: $2.88 million
• Optionable: Optionable
• Beta: 0.13